Skip to main content
. Author manuscript; available in PMC: 2022 Aug 3.
Published in final edited form as: Eur J Endocrinol. 2021 Aug 3;185(3):355–364. doi: 10.1530/EJE-21-0346

Table 2:

Laboratory levels upon provocation tests.

Basal Stimulated Mean difference (95% CI) Percent change p-value
Hypertonic saline infusion
Plasma copeptin (pmol/l) 4.8 (2.4) 33.5 (14.8) 28.7 (21.7, 35.6) 819.2 (762.4) <0.001
Plasma oxytocin (pg/ml) 0.4 (0.2) 0.6 (0.3) 0.2 (0.08–0.34) 89.7 (136.6) 0.003
Arginine infusion
Plasma copeptin (pmol/l) 5.4 (3.8) 9.4 (4.9) 4.0 (3.1, 4.8) 79.1 (54.3) <0.001
Plasma oxytocin (pg/ml) 0.5 (0.3) 0.4 (0.2) −0.04 (−0.15, 0.06) 2.1 (55.6) 0.4
Oral macimorelin test
Plasma growth hormone (ng/ml) 12.5 (16.6) 97.1 (40.0) 85.3 (67.9, 102.7) 13514.0 (19061.8) <0.001
Plasma copeptin (pmol/l) 5.0 (2.3) 4.6 (2.3) −0.38 (−0.6, −0.2) −7.8 (11.1) 0.002
Plasma oxytocin (pg/ml) 49.7 (23.3) 40.2 (16.1) −10.6 (−21.4, 0.2) −9.5 (36.7) 0.05

Basal and stimulated laboratory levels upon the hypertonic saline infusion, the arginine infusion and the oral macimorelin test with mean difference and percent change between basal and stimulated levels.

Continuous variables are presented as mean (standard deviation). Percent change represents the percent increase or decrease from basal and stimulated levels. Two group comparison was computed using the paired t-test.